PHUONG JULIA BANH: Open Payments
NPI 1942685128 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,746 in 134 payments from 22 companies in 2025. Trend: 2023 $2,258 · 2024 $2,548 · 2025 $2,746
Food & beverage: $2,746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $866 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $251 |
| QOL Medical, LLC | 10 | $232 |
| Ardelyx, Inc. | 12 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $190 |
| Madrigal Pharmaceuticals | 7 | $158 |
| Phathom Pharmaceuticals, Inc. | 6 | $138 |
| GENZYME CORPORATION | 4 | $102 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| Ipsen Biopharmaceuticals, Inc | 3 | $64 |
Products named: RINVOQ, SKYRIZI, Sucraid, ENTYVIO, IBSRELA, DUPIXENT, REZDIFFRA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
